|
Market Closed -
Athens S.E.
10:10:27 2026-10-02 EDT
|
5-day change | 1st Jan Change | ||
| 1.568 EUR | +1.16% |
|
-0.13% | +61.65% |
| 09-17 | Lavipharm S.A. Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
| 06-24 | Lavipharm S.A. announces Annual dividend, payable on July 24, 2026 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| LAVIPHARM S.A. | Generic Pharmaceuticals | +1.16% | -0.13% | +61.65% | +93.58% | +14.62% | 298M |  | |  |
- Stock Market
- Stocks
- LAVI Stock
- Charts Lavipharm S.A.
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
